| Literature DB >> 30446383 |
Bing Wu1, Song Zhang1, Zengli Guo1, Gang Wang2, Ge Zhang3, Ling Xie4, Jitong Lou5, Xian Chen4, Di Wu6, Wolfgang Bergmeier7, Junnian Zheng8, Yisong Y Wan9.
Abstract
Pathogenic Th17 (pTh17) cells drive inflammation and immune-pathology, but whether pTh17 cells are a Th17 cell subset whose generation is under specific molecular control remains unaddressed. We found that Ras p21 protein activator 3 (RASA3) was highly expressed by pTh17 cells relative to non-pTh17 cells and was required specifically for pTh17 generation in vitro and in vivo. Mice conditionally deficient for Rasa3 in T cells showed less pathology during experimental autoimmune encephalomyelitis. Rasa3-deficient T cells acquired a Th2 cell-biased program that dominantly trans-suppressed pTh17 cell generation via interleukin 4 production. The Th2 cell bias of Rasa3-deficient T cells was due to aberrantly elevated transcription factor IRF4 expression. RASA3 promoted proteasome-mediated IRF4 protein degradation by facilitating interaction of IRF4 with E3-ubiquitin ligase Cbl-b. Therefore, a RASA3-IRF4-Cbl-b pathway specifically directs pTh17 cell generation by balancing reciprocal Th17-Th2 cell programs. These findings indicate that a distinct molecular program directs pTh17 cell generation and reveals targets for treating pTh17 cell-related pathology and diseases.Entities:
Keywords: Cbl-b; EAE disease; IL-4; IRF4; RASA3; pathogenic Th17 cell; pathogenic Th17-Th2 reciprocal programs
Mesh:
Substances:
Year: 2018 PMID: 30446383 PMCID: PMC6249088 DOI: 10.1016/j.immuni.2018.09.004
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745